9999999997-15-013140.txt : 20150903 9999999997-15-013140.hdr.sgml : 20150903 20150903122950 ACCESSION NUMBER: 9999999997-15-013140 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150903 DATE AS OF CHANGE: 20150903 20150903 20150903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 151091304 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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